JDD Buzz Series | Minoxidil for Scarring Alopecia: Is it Safe and Effective?
214572145721457
Topical minoxidil and, more recently, low-dose oral minoxidil are often used to treat hair disorders. But are these treatments safe and effective for scarring alopecia? A scoping review published in the March issue of the Journal of Drugs in Dermatology sought to determine what research says about the use of these treatments for central centrifugal cicatricial alopecia, frontal fibrosing alopecia, …
Topical minoxidil and, more recently, low-dose oral minoxidil are often used to treat hair disorders. But are these treatments safe and effective for scarring alopecia? A scoping review published in the March issue of the Journal of Drugs in Dermatology sought to determine what research says about the use of these treatments for central centrifugal cicatricial alopecia, frontal fibrosing alopecia, … Continue reading "JDD Buzz Series | Minoxidil for Scarring Alopecia: Is it Safe and Effective?"
Glamour recently posted an online article about how to grow hair faster. Does research support the use of supplements for hair growth? How quickly can patients expect to see results from any hair interventions?
For expert advice, I reached out to Amy McMichael, MD, FAAD, professor and chair of the department of dermatology at Wake Forest University School of Medicine.
When a patient asks how … 
At ODAC 2023, we had the opportunity to learn about cicatricial alopecias from renowned dermatologist and hair expert Dr. Amy McMichael, Professor of Dermatology at Wake Forest University School of Medicine.
First, we considered a framework to check for cicatricial alopecias. This is particularly important because if we can identify cicatricial alopecia, we can make sure we are treating the rig … 
INTRODUCTION
Alopecia areata (AA) is a condition characterized by nonscarring hair loss. Cases of alopecia areata are most commonly seen in patients under age 30 and are frequently idiopathic. In this report, we discuss a woman in her 50s who developed AA shortly after receiving the Tdap vaccine and after one year of guselkumab therapy.
CASE
A woman in her 50s with history of psor … 
Baricitinib (Olumiant®) is a once daily oral medication recently FDA approved for severe alopecia areata, which is defined as having a Severity of Alopecia Tool (SALT) score of 50 or higher.1 JAK inhibitors are a relatively new class of drug demonstrating efficacy and safety in a range of inflammatory skin disorders. Emerging studies have highlighted baricitinib’s effectiveness for conditions l … 